Screener
Medtronic MDT Neuroscience — Research and development expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Cardiovascular | Neuroscience | Medical Surgical | Total |
|---|---|---|---|---|
| Total consolidated net sales | $36,364 | |||
| Less: | ||||
| Cost of products sold, excluding amortization of intangible assets | 4,695 | 3,151 | 3,476 | 11,323 |
| Research and development expense | 1,136 | 616 | 686 | 2,438 |
| Selling, general, and administrative expense | 4,519 | 3,421 | 2,511 | 10,451 |
| Other segment items(3) | (46) | 36 | 14 | 4 |
| Reportable segment operating profit | $3,672 | $3,062 | $2,128 | $8,862 |
| Reconciliation of segment profit / (loss) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's neuroscience — research and development expense?
- Medtronic (MDT) reported neuroscience — research and development expense of $139M in Q1 2026.
- How has Medtronic's neuroscience — research and development expense changed year-over-year?
- Medtronic's neuroscience — research and development expense decreased by 6.7% year-over-year, from $149M to $139M.
- What is the long-term trend for Medtronic's neuroscience — research and development expense?
- Over 3 years (2023 to 2026), Medtronic's neuroscience — research and development expense has grown at a 2.4% compound annual growth rate (CAGR), from $573M to $616M.
- What does neuroscience — research and development expense mean?
- This includes all costs associated with the discovery, development, and clinical testing of new neuroscience technologies and therapies. It is a critical investment metric for assessing the segment's long-term innovation pipeline.
Ask your AI about Medtronic's neuroscience — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude